EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Outcomes following coronary artery bypass grafting with temporary left ventricular assist device support

Duc M Giao, Adham Makarem, Ameen M Basha, Chijioke Chukwudi, Ruby Singh, Boateng Kubi, George E Olverson, Thais Faggion Vinholo, Aabha Divya, Kamila Drezek, David A D'Alessandro, Eriberto Michel und 1 weitere

Frontiers in Cardiovascular Medicine · 21.05.2026 · 13

DOI: 10.3389/fcvm.2026.1842278 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Cardiovascular Medicine, online erschienen am 21.05.2026. Verfasst von Duc M Giao und 12 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiac Surgery, Corrigan Minehan Heart Center, Massachusetts General Hospital, Harvard Medical School, Boston, MA, United States. Die Arbeit nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The Impella 5.5 is a temporary mechanical circulatory support device consisting of a microaxial pump that unloads the left ventricle and provides hemodynamic support, but data in bypass grafting (CABG) are limited.

Methods

We conducted a single-center retrospective case series of adult patients who underwent isolated CABG with perioperative Impella 5.5 support between July 2020 and May 2024. Perioperative support was defined as implantation before separation from cardiopulmonary bypass (CPB) or immediately after CPB wean. Patients with prior mechanical circulatory support, preoperative Impella as the primary indication, or concomitant/reoperative cardiac surgery were excluded. Clinical characteristics, procedural details, and early outcomes were obtained from the electronic medical record.

Results

Sixteen patients met inclusion criteria. Median age was 59 years (range: 51–90 years), 93.8% were male, and 75.0% self-identified as White. Median preoperative LVEF was 20.5% (IQR: 15–25). Median Impella support duration was 6.97 days (IQR: 3.7–20.3 days). The device was implanted before CPB separation in 8 patients (50.0%) and immediately after CPB wean in 8 (50.0%); 93.8% were implanted via a right axillary graft. Thirteen patients (81.3%) were successfully weaned, and 1 patient (6.3%) was bridged to HeartMate 3. Two patients (12.5%) died before device explantation, and 1 additional patient died later during the same hospitalization after explantation, yielding an overall in-hospital mortality of 3 patients (18.8%). Rhythm complications occurred in 9 patients (56.3%), most commonly rapid atrial fibrillation (31.3%); sustained ventricular tachycardia occurred in 2 (12.5%), with 1 death. One intrapump thrombus required device exchange; no major bleeding or access-site infections occurred.

Conclusion

Impella 5.5 support in high-risk CABG with LV dysfunction was feasible in selected patients and may serve as an adjunct to surgical revascularization.

Schlagwörter

Stichwörter der Autor:innen

CABGLVADhigh-risk cardiac surgeryimpellamechanical circulatory support (MCS)

Autor:innen und Institutionen

  • Division of Cardiac Surgery, Corrigan Minehan Heart Center, Massachusetts General Hospital, Harvard Medical School, Boston, MA, United States.
  • Department of Cardiac Surgery, Smidt Heart Institute, Cedars Sinai Medical Center, Los Angeles, CA, United States.
  • Division of Cardiac Surgery, University of Calgary, Calgary, AB, Canada.
  • Division of Cardiac Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, United States.

Zitieren

APA

Giao, D. M., Makarem, A., Basha, A. M., Chukwudi, C., Singh, R., Kubi, B., Olverson, G. E., Faggion Vinholo, T., Divya, A., Drezek, K., A D'Alessandro, D., Michel, E., & Osho, A. A. (2026). Outcomes following coronary artery bypass grafting with temporary left ventricular assist device support. Frontiers in Cardiovascular Medicine, 13. https://doi.org/10.3389/fcvm.2026.1842278

Vancouver

Giao DM, Makarem A, Basha AM, Chukwudi C, Singh R, Kubi B, et al. Outcomes following coronary artery bypass grafting with temporary left ventricular assist device support. Frontiers in Cardiovascular Medicine. 2026;13. doi:10.3389/fcvm.2026.1842278

BibTeX
@article{Giao2026,
  author = {Giao, Duc M and Makarem, Adham and Basha, Ameen M and Chukwudi, Chijioke and Singh, Ruby and Kubi, Boateng and Olverson, George E and Faggion Vinholo, Thais and Divya, Aabha and Drezek, Kamila and A D'Alessandro, David and Michel, Eriberto and Osho, Asishana A},
  title = {Outcomes following coronary artery bypass grafting with temporary left ventricular assist device support},
  journal = {Frontiers in Cardiovascular Medicine},
  year = {2026},
  volume = {13},
  doi = {10.3389/fcvm.2026.1842278}
}
Kostenlos starten →